4//SEC Filing
Murdock Hunter R. 4
Accession 0000950170-25-088105
CIK 0001579428other
Filed
Jun 17, 8:00 PM ET
Accepted
Jun 18, 9:16 PM ET
Size
18.6 KB
Accession
0000950170-25-088105
Insider Transaction Report
Form 4
Murdock Hunter R.
General Counsel
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2025-06-17−7,500→ 37,383 totalExercise: $29.91From: 2023-03-04Exp: 2032-03-04→ Common Stock (7,500 underlying) - Sale
Common Stock
2025-06-16$102.42/sh−7,500$768,150→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-06-18−7,500→ 29,883 totalExercise: $29.91From: 2023-03-04Exp: 2032-03-04→ Common Stock (7,500 underlying) - Exercise/Conversion
Common Stock
2025-06-16$29.91/sh+7,500$224,325→ 7,500 total - Sale
Common Stock
2025-06-17$100.26/sh−7,500$751,950→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-06-16−7,500→ 44,883 totalExercise: $29.91From: 2023-03-04Exp: 2032-03-04→ Common Stock (7,500 underlying) - Sale
Common Stock
2025-06-18$100.90/sh−7,500$756,750→ 0 total - Exercise/Conversion
Common Stock
2025-06-18$29.91/sh+7,500$224,325→ 7,500 total - Exercise/Conversion
Common Stock
2025-06-17$29.91/sh+7,500$224,325→ 7,500 total
Footnotes (5)
- [F1]Such transaction was pursuant to a pre-approved 10b5-1 plan.
- [F2]Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options.
- [F3]Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $101.01 and $104.09
- [F4]Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $100.00 and $101.53.
- [F5]Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $100.00 and $101.96.
Documents
Issuer
Axsome Therapeutics, Inc.
CIK 0001579428
Entity typeother
Related Parties
1- filerCIK 0001934008
Filing Metadata
- Form type
- 4
- Filed
- Jun 17, 8:00 PM ET
- Accepted
- Jun 18, 9:16 PM ET
- Size
- 18.6 KB